Stay updated on Immunotherapy in Surgically Resectable HNSCC Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy in Surgically Resectable HNSCC Clinical Trial page.
Latest updates to the Immunotherapy in Surgically Resectable HNSCC Clinical Trial page
- Check2 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in its functionality.SummaryDifference0.2%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check39 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the study's location.SummaryDifference2%
- Check53 days agoChange DetectedThe website has added new features while removing detailed options for participant groups, interventions, and various data fields for downloads.SummaryDifference3%
- Check60 days agoChange DetectedSeveral links related to Ipilimumab and Nivolumab, as well as various PubMed articles and government health resources, have been removed from the website.SummaryDifference0.5%
- Check68 days agoChange DetectedThe website has been updated to version v2.12.2, with new links to various PubMed articles and additional data fields available for download.SummaryDifference4%
Stay in the know with updates to Immunotherapy in Surgically Resectable HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy in Surgically Resectable HNSCC Clinical Trial page.